Eugene

[email protected]

LATEST

Teva, P&G Agree to End Consumer Healthcare JV
By

By
Teva Pharmaceutical Industries and the Procter & Gamble Company have agreed to terminate the PGT Healthcare partnership that the two companies established in 2011 to market over-the-counter (OTC) medicines. The…

Cell and Gene Therapy Catapult Opens $83.8-Million Mfg Plant
By

By
Cell and Gene Therapy Catapult (CGT Catapult), a center of excellence funded by Innovate UK, the UK government’s innovation agency, to support cell-therapy organizations, has opened a cell- and gene-…

Grand River Aseptic Manufacturing Expands Sterile Manufacturing
By

By
Grand River Aseptic Manufacturing (GRAM), a Grand Rapids, Michigan-based provider of sterile-manufacturing services, has purchased a Bausch+Ströbel fully integrated high-speed filling line with a SKAN isolator. The Bausch+Ströbel filler can…

Dipharma To Acquire CRO Kalexsyn
By

By
Dipharma, a Baranzate, Italy-headquartered active pharmaceutical ingredients manufacturer, has agreed to acquire Kalexsyn, a Kalamazoo, Michigan-headquartered contract research organization (CRO) providing chemistry services to the biotechnology and pharmaceutical industry. Founded…

Catalent To Invest $5 Million at HQ for New Drug Development Center of Excellence
By

By
Catalent Pharma Solutions plans to invest $5 million in the creation of a new drug development center of excellence (CoE) at its Somerset, New Jersey facility and headquarters. The investment…

AMRI Signs 10-Year, $39.5-Million NIH Pact
By

By
AMRI, a contract research, development, and manufacturing organization, has renewed a 10-year contract worth up to $39.5 million with the National Institutes of Health (NIH) Blueprint Neurotherapeutics Network (BPN). The…

Sharp Invests $11 Million in Injectable, Cold-Chain Capabilities
By

By
Sharp Packaging Services, a part of UDG Healthcare and a company in contract packaging and clinical supply services, has invested $11 million to increase its global cold-storage and syringe assembly…

WuXi AppTec in Supply Pact
By

By
Phoenix Molecular Designs (PhoenixMD), a Vancouver, Canada-headquartered biopharmaceutical company designing cancer therapeutics, has partnered with STA Pharmaceutical, a WuXi AppTec company, to manufacture PMD-026, a first-in-class, specific ribosomal S6 kinase…

Heritage Pharma Makes Executive Leadership Changes
By

By
Heritage Pharmaceuticals, an East Brunswick, New Jersey-based specialty generic pharmaceutical company, has appointed William S. Marth, former President and Chief Executive Officer (CEO) of AMRI, as President and CEO, North…

UCB Buys Rights To Anti-Epilepsy Nasal Spray
By

By
UCB has agreed to acquire from Proximagen, a Cambridge, UK-based pharmaceutical company, the rights to USL261, an investigational midazolam formulation as a nasal spray, as an intended rescue treatment for…